BenevolentAI, a pioneering biotechnology company headquartered in Great Britain, is at the forefront of drug discovery and development. Founded in 2013, the company leverages advanced artificial intelligence to accelerate the identification of novel therapeutics, particularly in areas such as neurology and oncology. With a strong operational presence across Europe and North America, BenevolentAI has achieved significant milestones, including partnerships with leading pharmaceutical firms and successful clinical trials. Its unique platform integrates vast datasets to uncover insights that traditional methods may overlook, positioning the company as a leader in the AI-driven drug development landscape. Recognised for its innovative approach, BenevolentAI continues to push the boundaries of science, aiming to transform the way medicines are discovered and developed for patients worldwide.
How does BenevolentAI's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
BenevolentAI's score of 38 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, BenevolentAI reported total carbon emissions of approximately 5,904,400 kg CO2e. This figure includes Scope 1 emissions of about 282,000 kg CO2e, Scope 2 emissions of approximately 125,600 kg CO2e (location-based), and a significant contribution from Scope 3 emissions, which totalled around 5,496,800 kg CO2e. Notably, the majority of Scope 3 emissions stemmed from purchased goods and services, accounting for about 5,191,100 kg CO2e. Comparatively, in 2022, BenevolentAI's total emissions were approximately 7,310,600 kg CO2e, with Scope 1 emissions at about 246,900 kg CO2e and Scope 2 emissions at around 103,900 kg CO2e (location-based). The Scope 3 emissions for that year were significantly higher, reaching approximately 6,959,800 kg CO2e, primarily driven by purchased goods and services. Despite the lack of specific reduction targets or initiatives disclosed, BenevolentAI's emissions data is cascaded from its parent company, BenevolentAI S.A., indicating a corporate commitment to transparency in emissions reporting. The company has not yet established Science-Based Targets Initiative (SBTi) reduction targets or other formal climate pledges, which places it in a broader industry context where many organisations are increasingly setting ambitious climate goals. Overall, BenevolentAI's emissions data reflects a substantial carbon footprint, particularly in Scope 3 emissions, highlighting the need for ongoing assessment and potential strategies for emissions reduction in the future.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 246,900 | 000,000 |
| Scope 2 | 103,900 | 000,000 |
| Scope 3 | 6,959,800 | 0,000,000 |
BenevolentAI's Scope 3 emissions, which decreased by 21% last year and decreased by approximately 21% since 2022, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 94% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BenevolentAI has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

